These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 4015950

  • 21. Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-arm randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861).
    Bruning PF, Bonfrèr JM, Wildiers J, Jassem J, Beex LV, Schornagel J, Nooijen WJ.
    J Steroid Biochem Mol Biol; 1990 Dec 20; 37(6):1013-9. PubMed ID: 2149501
    [Abstract] [Full Text] [Related]

  • 22. Aminoglutethimide--a new endocrine therapy in breast cancer. A cancer research review.
    Harris AL.
    Exp Cell Biol; 1985 Dec 20; 53(1):1-8. PubMed ID: 3881300
    [Abstract] [Full Text] [Related]

  • 23. The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients.
    Jones AL, MacNeill F, Jacobs S, Lonning PE, Dowsett M, Powles TJ.
    Eur J Cancer; 1992 Dec 20; 28A(10):1712-6. PubMed ID: 1389491
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione.
    Brodie AM, Longcope C.
    Endocrinology; 1980 Jan 20; 106(1):19-21. PubMed ID: 6765930
    [Abstract] [Full Text] [Related]

  • 25. Aminoglutethimide dose and hormone suppression in advanced breast cancer.
    Harris AL, Dowsett M, Jeffcoate SL, Smith IE.
    Eur J Cancer Clin Oncol; 1983 Apr 20; 19(4):493-8. PubMed ID: 6222901
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women.
    van der Wall E, Donker TH, de Frankrijker E, Nortier HW, Thijssen JH, Blankenstein MA.
    Cancer Res; 1993 Oct 01; 53(19):4563-6. PubMed ID: 8402628
    [Abstract] [Full Text] [Related]

  • 27. [A new principle in endocrine therapy of metastatic breast cancer: aminoglutethimide, an antiestrogen with aromatase-inhibiting action].
    Drees N.
    Onkologie; 1984 Feb 01; 7(1):52-6. PubMed ID: 6369209
    [No Abstract] [Full Text] [Related]

  • 28. In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.
    Geisler J, King N, Anker G, Ornati G, Di Salle E, Lønning PE, Dowsett M.
    Clin Cancer Res; 1998 Sep 01; 4(9):2089-93. PubMed ID: 9748124
    [Abstract] [Full Text] [Related]

  • 29. Treatment with formestane alone and in combination with aminoglutethimide in heavily pretreated breast cancer patients: clinical and endocrine effects.
    Geisler J, Johannessen DC, Anker G, Lønning PE.
    Eur J Cancer; 1996 May 01; 32A(5):789-92. PubMed ID: 9081355
    [Abstract] [Full Text] [Related]

  • 30. Low-dose aminoglutethimide in treatment of advanced breast cancer.
    Stuart-Harris R, Dowsett M, Bozek T, McKinna JA, Gazet JC, Jeffcoate SL, Kurkure A, Carr L, Smith IE.
    Lancet; 1984 Sep 15; 2(8403):604-7. PubMed ID: 6147642
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
    Brodie AM, Santen RJ.
    Crit Rev Oncol Hematol; 1986 Sep 15; 5(4):361-96. PubMed ID: 3094971
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
    Santen RJ, Santner S, Davis B, Veldhuis J, Samojlik E, Ruby E.
    J Clin Endocrinol Metab; 1978 Dec 15; 47(6):1257-65. PubMed ID: 263348
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.